We found striking evidence that TREM2 transcript associations are region-specific, with high cortical TREM2 relating to both amyloid pathology and clinical AD, while high caudate TREM2 was associated with microglial activation, less AD neuropathology, and a slower rate of global cognitive decline in AD cases. Here, TREM2 is linked to Alzheimer disease.